THC Stock Zooms Up By 8.14% On Receiving Two Major Cannabis Permits

As per the ASX announcement dated 21st December 2018, the THC Global Group Limited (ASX: THC), formerly The Hydroponics Company Ltd, announces approval of two major cannabis permits by its wholly owned subsidiary Canndeo Limited. The receipt of grants from the Office of Drug Control (ODC), will allow the cultivation and production of the company’s proprietary high CBD strains at its Queensland Growing and R&D facility.

At the request of the company releasing major announcement, ASX placed the securities of THC Global Group Ltd on a trading halt effective 19th December 2018. The securities resumed trading today. The shares of the company rallied to 46.5 cents, up by 8.14% at the close of the trading session.

The company is expanding the cannabis plant supply for processing into cannabis oils and other medicinal cannabis drugs at its Australian manufacturing facility. The granting of these licenses complements THC Global’s farm-to-pharma medicinal cannabis strategy. Additionally, the company aims at maximizing yields and quality in its full-scale cultivation at Australian growing facilities. The company will be henceforth assisted by the data generated through the research under the permits.

THC Global Group is a biopharmaceutical company involved in providing medicinal cannabis products. THC has two high-grade medicinal cannabis growing sites based in Australia. One is “NSW Growing Site” with a large-scale capacity of up to 600k plants every year. The second is “Queensland Growing and R&D facility” capable of producing expected 850k strain clones per year

The company also operates a global hydroponics business, focusing on the manufacturing and distribution of hydroponics equipment, materials, and nutrients across North America, via Crystal Mountain Manufacturing (100% Owned by THC Limited). As announced on 28th November 2018, THC also expanded its reach across New Zealand medicinal cannabis market. This is an excellent step considering the recent proposal for cannabis legalization for New Zealand patients.

The THC Global has two additional manufacturing licence applications under review over two areas- ODC permitted growing and R&D facility, and its large-scale manufacturing facility.

The company is in a unique position with strong potential of establishing its mark as a leading cannabis producer. It has fully built production ready sites, submitted for licencing and permitting while some of its peer companies in the industry are struggling for the license in the pre-construction phase.

The company’s Global CEO, Ken Charteris commented stated that the company is looking forward to establishing itself as one of the only Australian companies to have production ready facilities with licencing and permitting at an advanced stage soon. The management is planning to partner with global commercial partners in further research and development activities on the proprietary strains.

With a meagre performance change of 6.17% since its inception on May 4, 2017, THC stock has been on a downtrend this year. The company’s stock offers a negative YTD return of 38.13% till date.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.


Disclaimer
The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

Ad

GET A FREE STOCK REPORT


Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.


   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK